In the US, Minipress (prazosin systemic) is a member of the drug class antiadrenergic agents, peripherally acting and is used to treat Benign Prostatic Hyperplasia, Heart Failure, High Blood Pressure and Raynaud's Syndrome.

US matches:

Ingredient matches for Minipress


Prazosin hydrochloride (a derivative of Prazosin) is reported as an ingredient of Minipress in the following countries:

  • Australia
  • Brazil
  • Ethiopia
  • France
  • Hong Kong
  • Hungary
  • Japan
  • Malaysia
  • Oman
  • Romania
  • Sudan
  • Taiwan
  • Thailand
  • United States

International Drug Name Search

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.